Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. SPY
3. ALAR
4. PRYMY
5. SKA-B
6. PBA
7. CCH:LN
8. META
9. CCHGY
10. PRY:IM

Go back to Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

Syros Pharmaceuticals (SYRS) Tops Q2 EPS by 1c

August 5, 2021 8:20 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q2 EPS of ($0.36), $0.01 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $4.13 million.

For earnings history and earnings-related data on Syros Pharmaceuticals (SYRS) click here.

... More